SBIR-STTR Award

Generation of Selective Antisera for Immunocytochemistry
Award last edited on: 7/29/03

Sponsored Program
STTR
Awarding Agency
NIH : NIMH
Total Award Amount
$99,689
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Stuart A Tobet

Company Information

Affinity Bioreagents Inc (AKA: ABR)

4620 Technology Drive Suite 600
Golden, CO 80403
   (303) 278-4535
   affinity@bioreagents.com
   www.bioreagents.com

Research Institution

Eunice Kennedy Shriver Center

Phase I

Contract Number: 1R41MH058500-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1998
Phase I Amount
$99,689
Gonadal steroid receptors acting as nuclear transcription factors are key polypeptides for determining functions, and multidimensional immunological tools to study these receptors are strongly needed. This proposal concentrates on creating probes for the newly cloned estrogen receptor beta because virtually no immunological reagents are available for its study. Our approach to generating such tools will provide a strategy for defining an immunological product spectrum for many polypeptides of importance for mental health. The strategy follows 3 themes: (1) peptide sequences that are low in certain basic amino acids (especially lysine) which are most susceptible to aldehyde fixation are preferable for generating antisera which optimize utility in immunocytochemistry; (2) antisera which recognize different sequences within the same polypeptide provide the optimal method for establishing polypeptide localization; and (3) antisera which differentiate the phosphorylation state of epitopes are important for establishing polypeptide activation. The proposed products will greatly expand researchers' ability to characterize the roles of specific polypeptides in the central nervous system

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----